Decision soon on Covid-19 vaccine availability in country: NCOC

Published December 24, 2020
The National Command and Operation Centre (NCOC) on Wednesday announced that the government was in close liaison with the world’s leading vaccine manufacturers, including those in China, and would soon make a decision about its availability in the country. — AFP/File
The National Command and Operation Centre (NCOC) on Wednesday announced that the government was in close liaison with the world’s leading vaccine manufacturers, including those in China, and would soon make a decision about its availability in the country. — AFP/File

ISLAMABAD: Amid reports pouring in from various parts of the world about start of Covid-19 vaccinations, the National Command and Operation Centre (NCOC) on Wednesday announced that the government was in close liaison with the world’s leading vaccine manufacturers, including those in China, and would soon make a decision about its availability in the country at the earliest.

In a statement, the NCOC said the government was regularly reviewing developments taking place around the globe, including data from phase 3 trials.

“These steps will lead to a final decision about early availability of the vaccine in Pakistan,” it said on the day the country recorded 2,142 new Covid-19 cases with 84 deaths, taking the overall death toll to 9,558. There were 37,904 active Covid cases in the country on Wednesday.

University of Health Sciences Vice Chancellor and Scientific Task Force on Covid-19 member Dr Javed Akram disclosed that 15,000 people, 80 per cent of the total volunteers, had been administered Chinese vaccine expressing the hope that the trial would end in December.

Govt in close liaison with world’s leading manufacturers

In Pakistan, the clinical trial of the Chinese vaccine began in September with the initial sample size of 10,000 volunteers. However, later the number was enhanced to 18,000.

The vaccine is ribonucleic acid based and will generate antibodies against the spikes as a result of which the virus will not be able to attach itself to lungs.

“Though some of the volunteers who were administered Pfizer-BioNtech vaccine were hospitalised, not a single incident has occurred with the Chinese vaccine in Pakistan. Once the trial is completed, the process of vaccine registration will start. We will not waste a single minute as the country is losing almost 100 people’s lives daily because of the pandemic,” he had stated.

Meanwhile, the data released by the NCOC shows that over the last 24 hours, most deaths occurred in Punjab, followed by Sindh. As many as 39 deaths were reported from various parts of Punjab, followed by 21 in Sindh and 10 in Khyber Pakhtunkhwa. Of 84 deaths over the last 24 hours, according to the NCOC, 47 patients died on ventilators.

Published in Dawn, December 24th, 2020

Opinion

Editorial

Last call
15 Nov, 2024

Last call

IT does not seem prudent for a party of PTI’s heft to have issued a ‘final call’ for a ‘final’ protest. Politics is, by its very
Mini budget talk
15 Nov, 2024

Mini budget talk

NO matter how much Pakistan’s finance managers try to downplay the prospect of a ‘mini budget’ to pull off a...
Diabetes challenge
15 Nov, 2024

Diabetes challenge

AMONGST the many public health challenges confronting Pakistan, diabetes arguably does not get the attention it...
China security ties
Updated 14 Nov, 2024

China security ties

If China's security concerns aren't addressed satisfactorily, it may affect bilateral ties. CT cooperation should be pursued instead of having foreign forces here.
Steep price
14 Nov, 2024

Steep price

THE Hindu Kush-Himalayan region is in big trouble. A new study unveiled at the ongoing COP29 reveals that if high...
A high-cost plan
14 Nov, 2024

A high-cost plan

THE government has approved an expensive plan for FBR in the hope of tackling its deep-seated inefficiencies. The...